208 related articles for article (PubMed ID: 31934812)
21. 6-gingerol prevents adipogenesis and the accumulation of cytoplasmic lipid droplets in 3T3-L1 cells.
Tzeng TF; Liu IM
Phytomedicine; 2013 Apr; 20(6):481-7. PubMed ID: 23369342
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory efficacy of lutein on adipogenesis is associated with blockage of early phase regulators of adipocyte differentiation.
Gopal SS; Eligar SM; Vallikannan B; Ponesakki G
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158812. PubMed ID: 32920140
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha.
Miller CW; Casimir DA; Ntambi JM
Endocrinology; 1996 Dec; 137(12):5641-50. PubMed ID: 8940395
[TBL] [Abstract][Full Text] [Related]
24. Alpha-lipoic acid attenuates adipocyte differentiation and lipid accumulation in 3T3-L1 cells via AMPK-dependent autophagy.
Hahm JR; Noh HS; Ha JH; Roh GS; Kim DR
Life Sci; 2014 Apr; 100(2):125-132. PubMed ID: 24530288
[TBL] [Abstract][Full Text] [Related]
25. Low-Dose Bisphenol-A Impairs Adipogenesis and Generates Dysfunctional 3T3-L1 Adipocytes.
Ariemma F; D'Esposito V; Liguoro D; Oriente F; Cabaro S; Liotti A; Cimmino I; Longo M; Beguinot F; Formisano P; Valentino R
PLoS One; 2016; 11(3):e0150762. PubMed ID: 26942597
[TBL] [Abstract][Full Text] [Related]
26. Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3-L1 cells.
Nakashima KI; Okamura M; Matsumoto I; Kameda N; Tsuboi T; Yamaguchi E; Itoh A; Inoue M
J Nat Med; 2023 Mar; 77(2):315-326. PubMed ID: 36607539
[TBL] [Abstract][Full Text] [Related]
27. Anti-obesity effects of kaempferol by inhibiting adipogenesis and increasing lipolysis in 3T3-L1 cells.
Torres-Villarreal D; Camacho A; Castro H; Ortiz-Lopez R; de la Garza AL
J Physiol Biochem; 2019 Feb; 75(1):83-88. PubMed ID: 30539499
[TBL] [Abstract][Full Text] [Related]
28. Study on Physiological Roles of Stimulation of Prostaglandin E2 Receptor Subtype EP2 in Urethral Function in Rats.
Kurihara R; Ishizu K; Takamatsu H; Yoshino T; Masuda N
Low Urin Tract Symptoms; 2016 May; 8(2):125-9. PubMed ID: 27111625
[TBL] [Abstract][Full Text] [Related]
29. Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3 T3-L1 cells.
Drira R; Chen S; Sakamoto K
Life Sci; 2011 Nov; 89(19-20):708-16. PubMed ID: 21945192
[TBL] [Abstract][Full Text] [Related]
30. Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase.
Fujimori K; Ueno T; Nagata N; Kashiwagi K; Aritake K; Amano F; Urade Y
J Biol Chem; 2010 Mar; 285(12):8880-6. PubMed ID: 20093363
[TBL] [Abstract][Full Text] [Related]
31. E2F1 Regulates Adipocyte Differentiation and Adipogenesis by Activating ICAT.
Chen J; Yang Y; Li S; Yang Y; Dai Z; Wang F; Wu Z; Tso P; Wu G
Cells; 2020 Apr; 9(4):. PubMed ID: 32326181
[TBL] [Abstract][Full Text] [Related]
32. Apigenin isolated from Daphne genkwa Siebold et Zucc. inhibits 3T3-L1 preadipocyte differentiation through a modulation of mitotic clonal expansion.
Kim MA; Kang K; Lee HJ; Kim M; Kim CY; Nho CW
Life Sci; 2014 Apr; 101(1-2):64-72. PubMed ID: 24582594
[TBL] [Abstract][Full Text] [Related]
33. Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation.
Tsuboi H; Sugimoto Y; Kainoh T; Ichikawa A
Biochem Biophys Res Commun; 2004 Sep; 322(3):1066-72. PubMed ID: 15336573
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen sulfide impacts on inflammation-induced adipocyte dysfunction.
Comas F; Latorre J; Cussó O; Ortega F; Lluch A; Sabater M; Castells-Nobau A; Ricart W; Ribas X; Costas M; Fernández-Real JM; Moreno-Navarrete JM
Food Chem Toxicol; 2019 Sep; 131():110543. PubMed ID: 31154084
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane inhibits mitotic clonal expansion during adipogenesis through cell cycle arrest.
Choi KM; Lee YS; Sin DM; Lee S; Lee MK; Lee YM; Hong JT; Yun YP; Yoo HS
Obesity (Silver Spring); 2012 Jul; 20(7):1365-71. PubMed ID: 22282047
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl.
Iwamura R; Tanaka M; Okanari E; Kirihara T; Odani-Kawabata N; Shams N; Yoneda K
J Med Chem; 2018 Aug; 61(15):6869-6891. PubMed ID: 29995405
[TBL] [Abstract][Full Text] [Related]
37. Changes in Prostaglandin-associated Periorbital Syndrome After Switch from Conventional Prostaglandin F2α Treatment to Omidenepag Isopropyl in 11 Consecutive Patients.
Nakakura S; Terao E; Fujisawa Y; Tabuchi H; Kiuchi Y
J Glaucoma; 2020 Apr; 29(4):326-328. PubMed ID: 31913226
[TBL] [Abstract][Full Text] [Related]
38. Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species.
Pastel E; Pointud JC; Loubeau G; Dani C; Slim K; Martin G; Volat F; Sahut-Barnola I; Val P; Martinez A; Lefrançois-Martinez AM
Endocrinology; 2015 May; 156(5):1671-84. PubMed ID: 25730106
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes.
Kong CS; Kim JA; Eom TK; Kim SK
J Nutr Biochem; 2010 May; 21(5):438-43. PubMed ID: 19427183
[TBL] [Abstract][Full Text] [Related]
40. Euphorbiasteroid, a component of Euphorbia lathyris L., inhibits adipogenesis of 3T3-L1 cells via activation of AMP-activated protein kinase.
Park SJ; Park JH; Han A; Davaatseren M; Kim HJ; Kim MS; Hur HJ; Sung MJ; Hwang JT; Yang HJ; Kwon DY
Cell Biochem Funct; 2015 Jun; 33(4):220-5. PubMed ID: 25914364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]